EMMAUS LIFE SCIENCES, INC.
EMMACIK 0000822370
Revenue (TTM)
$10.58M
−25.2% YoY
Q1 May 2026
Net Income (TTM)
−$8.88M
−16.1% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.14
−20.0% YoY
Q1 May 2026
Gross Margin
92.5%
Q1 May 2026
Operating Margin
-14.0%
Q1 May 2026
Net Margin
-83.9%
Q1 May 2026
Free Cash Flow (TTM)
−$1.23M
Q1 May 2026
Cash
$1.07M
Q1 May 2026
Total Debt
$815.8K
Q1 May 2026
Shares Outstanding
70.19M sh
Q1 May 2026